copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
NCCN Expands Cancer Genetic Risk Assessment Guidelines - Medscape The National Comprehensive Cancer Network (NCCN) has expanded two cancer genetic risk assessment guidelines to meet the growing understanding of hereditary cancer risk and use of genetic tests in
NCCN: Test All Colorectal Cancers for Lynch Syndrome - Medscape HOLLYWOOD, Florida — The National Comprehensive Cancer Network (NCCN) now recommends that patients with colorectal cancer (CRC) be tested for Lynch syndrome The syndrome is the most common
NCCN: Consider Tomosynthesis for Mammography Screening For the first time, the National Comprehensive Cancer Network (NCCN) recommends that clinicians "consider" tomosynthesis as part of annual breast cancer screening
Guidelines for Ovarian Cancer Updated - Medscape A host of changes in the treatment of ovarian cancer are described in these new guidelines, including the option to deliver chemotherapy intraperitoneally, which significantly improves survival
Breast Cancer Guidelines Compared: ESMO vs NCCN - Medscape A comparison of breast cancer guidelines from two of the world's most prominent oncology organizations, the National Comprehensive Cancer Network (NCCN) and the European Society of Medical
Study Supports New NCCN Classification for Cutaneous SCC Patients with high- and very-high-risk cutaneous squamous cell carcinoma (CSCC), as defined by the 2022 National Comprehensive Cancer Network guidelines, have a significantly increased risk of
Retifanlimab Wins Upfront Indication for Anal Cancer - Medscape The National Comprehensive Cancer Network recommends other PD-1 blockers for second line treatment of anal cancer, but retifanlimab-dlwr is the first one to win a formal first-line indication